[Funding] Fission Pharma
Revised funding agreement for the DRP1-FIS1 inhibitor program (CerebrumDAO's own project pages call it "Fission Bio"; this proposal and VitaDAO's forum call it "Fission Pharma" — see the project page for that naming conflict). Originally a co-funded spinout with VitaDAO ($83,333 Cerebrum share of $333,333 total, per CDP-2); this revision has Cerebrum DAO solely operate the spinout under revised terms. Exact final revised total is not clearly isolable from the on-chain text.
Vote result
| Choice | Votes (NEURON) | Share |
|---|---|---|
| For | 7,410,542,234.999 | 98.2% |
| Against | 0 | 0.0% |
| Abstain | 138,055,935.22 | 1.8% |
Quorum: 3,870,000,000 NEURON